Skip to main content

9 Result(s)

within A. Glomstein Remove this filter

and

  1. No Access

    Article

    Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients

    Alpha-mannosidosis is a rare lysosomal storage disease. Hematopoietic SCT (HSCT) is usually recommended as a therapeutic option though reports are anecdotal to date. This retrospective multi institutional anal...

    M Mynarek, J Tolar, M H Albert, M L Escolar, J J Boelens… in Bone Marrow Transplantation (2012)

  2. No Access

    Article

    Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation

    In this population-based material from the five Nordic countries (Denmark, Finland, Iceland, Norway and Sweden), 2860 children below 15 years of age were diagnosed with acute lymphoblastic leukemia (ALL) from ...

    G Gustafsson, K Schmiegelow, E Forestier, N Clausen, A Glomstein, G Jonmundsson… in Leukemia (2000)

  3. Article

    IDENTIFICATION OF MICRODELETIONS SPANNING THE DIAMOND-BLACKFAN ANEMIA (DBA) LOCUS ON 19Q13 AND EVIDENCE FOR GENETIC HETEROGENEITY

    P Gustavsson, E Garelli, N Draptchinskaia, S Ball, T N Willing… in Pediatric Research (1999)

    Download PDF (96 KB) View Article

  4. No Access

    Article

    Allogeneic bone marrow transplantation in second remission of childhood acute lymphoblastic leukemia: a population-based case control study from the Nordic countries

    This study compares allogeneic BMT with conventional chemotherapy for childhood ALL in second remission. Seventy-five children were transplanted between July 1981 and December 1995. For each patient two contro...

    H Schroeder, G Gustafsson, UM Saarinen-Pihkala, A Glomstein… in Bone Marrow Transplantation (1999)

  5. Article

    QUALITY OF LIFE IN PATIENTS TREATED WITH A NATIONAL ALL PROTOCOL 15-10 YEARS EARLIER: IDM/HDM AND LATE EFFECTS? 123

    P J Moe, A Glomstein, B Madsen, A Holen in Pediatric Research (1997)

    Download PDF (96 KB) View Article

  6. No Access

    Article

    Hepatitis C virus seroconversion in a hemophiliac treated exclusively with solvent/detergent-treated clotting factor concentrate

    Tremendous efforts have been made to prevent the transmission of infectious agents by clotting factor concentrates. Blood donors are carefully selected, each blood donation is tested for common blood-transmiss...

    S. A. Evensen, H. Rollag, A. Glomstein in European Journal of Clinical Microbiology … (1995)

  7. No Access

    Article

    Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools

    The prevalence of antibodies against hepatitis C virus (HCV) in sera from 266 Norwegians with coagulation factor defects of different types and degrees of severity was assessed by an enzyme immunoassay. The ov...

    H. Rollag, S. A. Evesen, S. S. Fröland… in European Journal of Clinical Microbiology … (1990)

  8. No Access

    Article

    Serological markers of hepatitis B virus and cytomegalovirus infections in Norwegians with coagulation factor defects

    The prevalence of serological markers for present and past hepatitis B virus (HBV) infection and antibodies against cytomegalovirus (CMV) among Norwegians with coagulation factor defects was examined in serum ...

    H. Rollag, S. A. Evensen, S. S. Frøland… in Blut: Zeitschrift für die Gesamte Blutfors… (1990)

  9. No Access

    Article

    Clinical and pharmacologic studies with adriamycin-DNA complex in children with malignant disease

    During the last 4 years, we have studied the adriamycin-DNA complex originally developed by Trouet and co-workers (1972). This paper summarizes the results of our pharmacologic and clinical studies.

    S. O. Lie, K. K. Lie, A. Glomstein in Cancer Chemotherapy and Pharmacology (1979)